Product Information
INDAPAMIDE 1.25 MG TABLET is a generic product labeled by ANI Pharmaceuticals, Inc., priced at $0.1072 per EA under NDC 62559051001. Its NADAC has been published 437 times since Feb 14, 2018.
Strength
1.25 mg/1
Manufacturer
ANI Pharmaceuticals, Inc.NDC
62559051001
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
INDAPAMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA074299On Market Since
4/24/2017
Pharmacological Classes
Price Statistics
The NADAC for INDAPAMIDE 1.25 MG TABLET has been published 437 times since Feb 14, 2018, and over the history we have for it it has declined 53.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1072 per EA |
|---|---|
| All-time high | $0.2284 (Feb 14, 2018) |
| All-time low | $0.0837 (Nov 20, 2024) |
| 52-week high | $0.1091 |
| 52-week low | $0.0993 |
| Median price | $0.1243 |
| Average price | $0.1397 |
| Largest weekly change | -29.9% (Nov 20, 2024) |
| Weeks tracked | 437 |
| Tracking since | Feb 14, 2018 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of INDAPAMIDE 1.25 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for INDAPAMIDE 1.25 MG TABLET, manufactured by ANI Pharmaceuticals, Inc., is $0.1072 per EA (NDC 62559051001), effective Jun 24, 2026.
How has the price of INDAPAMIDE 1.25 MG TABLET changed over time?
Over the history we have for it, the NADAC for INDAPAMIDE 1.25 MG TABLET has declined 53.1%. It has been tracked across 437 weekly CMS publications since Feb 14, 2018.
What are the highest and lowest recorded NADAC prices for INDAPAMIDE 1.25 MG TABLET?
Since Feb 14, 2018, the NADAC for INDAPAMIDE 1.25 MG TABLET has ranged from a low of $0.0837 (Nov 20, 2024) to a high of $0.2284 (Feb 14, 2018), with a median of $0.1243 per EA.
Are there cheaper alternatives to INDAPAMIDE 1.25 MG TABLET?
2 NADAC-published products share the same active ingredient, strength, and dosage form as INDAPAMIDE 1.25 MG TABLET, but none are currently priced below it.
Who manufactures INDAPAMIDE 1.25 MG TABLET?
INDAPAMIDE 1.25 MG TABLET (NDC 62559051001) is labeled by ANI Pharmaceuticals, Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification